Norepinephrine 4mg Injection PCD Company in Maharashtra

Norepinephrine 4mg Injection Franchise Supplier in Gujarat

Norepinephrine 4mg Injection Manufacturer in Himachal Pradesh

Best PCD Pharma for Norepinephrine 4mg Injection in Telangana

Norepinephrine 4mg Injection Third Party Manufacturer in West Bengal
Norepinephrine 4mg Injection Exporter from India

Home/Products /nordine-injection-norepinephrine-4mg-injection

Nordine Injection

Composition : Norepinephrine (4mg) Injection

Dosage Form : Injection

Packaging Type : Ampule

Packaging : 5x2ml

Price : ₹45.96/-

Nordine Injection contains Norepinephrine (4mg), a powerful sympathomimetic drug that plays a crucial role in the management of severe hypotension and shock, particularly in critical care settings. Norepinephrine acts primarily on alpha-adrenergic receptors, leading to vasoconstriction—the narrowing of blood vessels. This action increases systemic vascular resistance and elevates blood pressure, helping restore circulation to vital organs when blood pressure drops dangerously low. It has a mild effect on beta-1 receptors as well, contributing to improved cardiac output in certain patients. Nordine is usually given as a continuous intravenous infusion in ICU environments, where close monitoring of blood pressure, heart rate, and organ function is essential. It is considered a life-saving medication during acute cardiovascular collapse and septic shock, often used in conjunction with fluid therapy and other supportive treatments. Its onset is rapid, and the dosage is titrated carefully to achieve the desired hemodynamic response. Because of its potency and the risks associated with misuse, it should only be administered by trained healthcare professionals in controlled clinical settings.


Read More

About the Product

Nordine Injection contains Norepinephrine (4mg), a powerful sympathomimetic drug that plays a crucial role in the management of severe hypotension and shock, particularly in critical care settings. Norepinephrine acts primarily on alpha-adrenergic receptors, leading to vasoconstriction—the narrowing of blood vessels. This action increases systemic vascular resistance and elevates blood pressure, helping restore circulation to vital organs when blood pressure drops dangerously low. It has a mild effect on beta-1 receptors as well, contributing to improved cardiac output in certain patients. Nordine is usually given as a continuous intravenous infusion in ICU environments, where close monitoring of blood pressure, heart rate, and organ function is essential. It is considered a life-saving medication during acute cardiovascular collapse and septic shock, often used in conjunction with fluid therapy and other supportive treatments. Its onset is rapid, and the dosage is titrated carefully to achieve the desired hemodynamic response. Because of its potency and the risks associated with misuse, it should only be administered by trained healthcare professionals in controlled clinical settings.


Common side effects may include headache, anxiety, or a slow heart rate. Serious reactions can involve arrhythmias, high blood pressure, or tissue necrosis if the injection leaks outside the vein.

Nordine Injection is indicated for the emergency treatment of acute hypotension due to septic, cardiogenic, or neurogenic shock, and also for low blood pressure following cardiac arrest.

This injection must only be given under continuous medical supervision, preferably through a central venous line. It should be diluted before use and is not suitable for self-administration under any circumstances.

Store below 25°C in a cool, dry place, away from light. Do not freeze. Discard any unused solution after opening or dilution. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation